Skip to content

Stem Cells

the 2013 event trilogy

  • Home
  • Canceld Events 2020
  • Stem Cell Ipsc
  • Suppliers
  • Stem Cell Products for Research
  • Stem Cells Research
  • Blog
  • Toggle search form

Stem cells and vascular dementia: from basic science to the clinic

Posted on April 10, 2020April 10, 2020 By Taylor No Comments on Stem cells and vascular dementia: from basic science to the clinic

Vascular dementia (VD) is the second most common cause of dementia following Alzheimer’s disease (AD). The major symptoms of VD including memory loss, language deficits and impairment of executive functions. Its specific etiology and pathogenesis remain unknown. Currently, treatment options of VD are still limited. The therapeutic strategies aim to control the vascular risk factors and improve the cognitive function. In recent years, cell therapy for neurodegenerative diseases has attracted a great deal of attention. Evidence suggested that stem cell transplantation could improve the symptoms of cerebral infarction and AD. Therefore, it may serve as a potential therapy for VD. We summarized the latest research results both in vitro and in vivo. Further, the clinical trial of stem cell transplantation in VD patients was also reviewed. Finally, the limitations and future directions of cell therapy in VD treatment were discussed.

Stem Cells Research

Post navigation

Previous Post: Crosstalk between Dental Pulp Stem Cells and Endothelial Cells Augments Angiogenic Factor Expression
Next Post: Newly synthesized peptide, Ara-27, exhibits significant improvement in cell-penetrating ability compared to conventional peptides

More Related Articles

Crosstalk between Dental Pulp Stem Cells and Endothelial Cells Augments Angiogenic Factor Expression Stem Cells Research

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Video Highlights

https://youtu.be/cMIClcmXZDI

 

 

Featured Supplier

RSS Latest News

  • An organoid co-culture model for probing systemic anti-tumor immunity in lung cancer
  • Multiomic profiling reveals that prostaglandin E2 reverses aged muscle stem cell dysfunction, leading to increased regeneration and strength
  • Human airway submucosal gland organoids to study respiratory inflammation and infection
  • Preferential tumor targeting of HER2 by iPSC-derived CAR T cells engineered to overcome multiple barriers to solid tumor efficacy
  • IGF2BP1 restricts the induction of human primordial germ cell fate in an m6A-dependent manner

 

Copyright © 2025 Stem Cells.

Powered by PressBook Blog WordPress theme